Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01975363 · ClinicalTrials.gov registry record · NA
Pilot Study of Curcumin for Women With Obesity and High Risk for Breast Cancer
A NA study, sponsored by Ohio State University Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 29
- Enrollment target
NCT01975363: Completed NA study, sponsored by Ohio State University Comprehensive Cancer Center.
NCT01975363 is a NA study that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 29 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01975363, a NA study, has completed, sponsored by Ohio State University Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
Study Summary
This randomized pilot clinical trial studies a nanoemulsion formulation of curcumin in reducing inflammatory changes in breast tissue in obese women at high risk for breast cancer. Curcumin may reduce inflammation in breast tissue and fat. This may affect the risk of developing breast cancer.
Primary Outcome
Confidence interval estimates will be obtained from the repeated analysis of variance and two-sample t tests.
Interventions
- DIETARY_SUPPLEMENT curcumin
- OTHER Biomarker analysis
- OTHER Assessment of Dietary Intake
- OTHER Daily Log
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2013-06 |
| Est. Completion | 2016-09-19 |
| Phase | NA |
What the finished NCT01975363 record still lists
NCT01975363 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 4 interventions - of which curcumin is the first listed.
NCT01975363 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01975363 about?
NCT01975363 is a clinical study titled "Pilot Study of Curcumin for Women With Obesity and High Risk for Breast Cancer". This randomized pilot clinical trial studies a nanoemulsion formulation of curcumin in reducing inflammatory changes in breast tissue in obese women at high risk for breast cancer. Curcumin may reduce inflammation in breast tissue and fat. This may affect the risk of developing breast cancer.
What is the current status of trial NCT01975363?
This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2013-06. Estimated completion is 2016-09-19.
What interventions are being tested in trial NCT01975363?
The interventions under investigation include: curcumin (DIETARY_SUPPLEMENT), Biomarker analysis (OTHER), Assessment of Dietary Intake (OTHER), Daily Log (OTHER).
Who is sponsoring clinical trial NCT01975363?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01975363's enrollment target sits among peer trials
29 1702nd of 2000 higher than 297 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia